Ekso Bionics Stock Price, News & Analysis (NASDAQ:EKSO)

$2.28 -0.15 (-6.17 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$2.28
Today's Range$2.27 - $2.49
52-Week Range$0.99 - $4.77
Volume831,350 shs
Average Volume928,593 shs
Market Capitalization$138.98 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.07

About Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics logoEkso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation to develop products for military applications, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EKSO
CUSIPN/A
Phone510-984-1761

Debt

Debt-to-Equity Ratio0.18%
Current Ratio6.09%
Quick Ratio5.73%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$14.22 million
Price / Sales9.60
Cash FlowN/A
Price / CashN/A
Book Value$0.30 per share
Price / Book7.60

Profitability

Trailing EPS($1.13)
Net Income$-23,470,000.00
Net Margins-343.53%
Return on Equity-323.00%
Return on Assets-113.54%

Miscellaneous

Employees108
Outstanding Shares59,900,000

Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Ekso Bionics shares reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) posted its quarterly earnings data on Wednesday, November, 8th. The company reported ($0.18) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.05. The business had revenue of $1.60 million for the quarter, compared to the consensus estimate of $2.40 million. Ekso Bionics had a negative net margin of 343.53% and a negative return on equity of 323.00%. View Ekso Bionics' Earnings History.

Where is Ekso Bionics' stock going? Where will Ekso Bionics' stock price be in 2017?

1 brokerages have issued 12-month price objectives for Ekso Bionics' stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Ekso Bionics' stock price to reach $4.00 in the next year. View Analyst Ratings for Ekso Bionics.

Who are some of Ekso Bionics' key competitors?

Who owns Ekso Bionics stock?

Ekso Bionics' stock is owned by many different of retail and institutional investors. Top institutional investors include National Planning Corp (0.87%) and Carl Domino Inc (0.31%). Company insiders that own Ekso Bionics stock include Amy Mcbride Wendell, Max Scheder-Bieschin, Russ Angold and Thomas Looby. View Institutional Ownership Trends for Ekso Bionics.

Who bought Ekso Bionics stock? Who is buying Ekso Bionics stock?

Ekso Bionics' stock was purchased by a variety of institutional investors in the last quarter, including National Planning Corp and Carl Domino Inc. Company insiders that have bought Ekso Bionics stock in the last two years include Amy Mcbride Wendell, Max Scheder-Bieschin and Thomas Looby. View Insider Buying and Selling for Ekso Bionics.

How do I buy Ekso Bionics stock?

Shares of Ekso Bionics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ekso Bionics' stock price today?

One share of Ekso Bionics stock can currently be purchased for approximately $2.28.

How big of a company is Ekso Bionics?

Ekso Bionics has a market capitalization of $138.98 million and generates $14.22 million in revenue each year. The company earns $-23,470,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis. Ekso Bionics employs 108 workers across the globe.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]


MarketBeat Community Rating for Ekso Bionics (EKSO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  143 (Vote Outperform)
Underperform Votes:  118 (Vote Underperform)
Total Votes:  261
MarketBeat's community ratings are surveys of what our community members think about Ekso Bionics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ekso Bionics (NASDAQ:EKSO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.00$6.00$11.00$11.00
Price Target Upside: 268.10% upside268.10% upside574.85% upside574.85% upside

Ekso Bionics (NASDAQ:EKSO) Consensus Price Target History

Price Target History for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ:EKSO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017B. RileyReiterated RatingBuy$4.00HighView Rating Details
10/14/2016SunTrust BanksInitiated CoverageBuyN/AView Rating Details
7/31/2016Rodman & RenshawReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 12/16/2015 forward)

Earnings

Ekso Bionics (NASDAQ:EKSO) Earnings History and Estimates Chart

Earnings by Quarter for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ EKSO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017Q3 2017($0.13)($0.18)$2.40 million$1.60 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.41)($0.38)$2.38 million$1.44 millionViewListenView Earnings Details
11/5/2015Q3 2015($0.04)($0.05)$2.55 million$2.92 millionViewN/AView Earnings Details
8/11/2015Q2 2015($0.04)($0.06)$2.00 million$2.11 millionViewN/AView Earnings Details
3/17/2015Q4 2014($0.03)($0.06)$1.48 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Ekso Bionics (NASDAQ:EKSO) Earnings Estimates

2017 EPS Consensus Estimate: ($1.21)
2018 EPS Consensus Estimate: ($0.93)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.41)($0.40)($0.41)
Q2 20172($0.34)($0.33)($0.34)
Q3 20172($0.35)($0.13)($0.24)
Q4 20172($0.35)($0.10)($0.23)
Q1 20182($0.39)($0.07)($0.23)
Q2 20182($0.39)($0.09)($0.24)
Q3 20182($0.37)($0.08)($0.23)
Q4 20182($0.36)($0.10)($0.23)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ekso Bionics (NASDAQ:EKSO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Ekso Bionics (NASDAQ EKSO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.32%
Institutional Ownership Percentage: 6.27%
Insider Trades by Quarter for Ekso Bionics (NASDAQ:EKSO)
Institutional Ownership by Quarter for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ EKSO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/22/2017Russ AngoldInsiderSell50,000$3.51$175,500.00View SEC Filing  
9/14/2017Amy Mcbride WendellDirectorBuy16,264$1.23$20,004.72View SEC Filing  
9/8/2017Thomas LoobyCEOBuy15,000$1.13$16,950.00View SEC Filing  
9/7/2017Max Scheder-BieschinCFOBuy10,000$1.13$11,300.00View SEC Filing  
8/23/2017Russ AngoldInsiderSell9,352$1.33$12,438.16View SEC Filing  
8/16/2017Russ AngoldInsiderSell28,254$1.53$43,228.62View SEC Filing  
8/15/2017Russ AngoldInsiderSell221,746$1.55$343,706.30View SEC Filing  
11/11/2016Max Scheder-BieschinCFOBuy1,000$4.00$4,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Ekso Bionics (NASDAQ EKSO) News Headlines

Source:
DateHeadline
BRIEF-Ekso Bionic Partners With HASOMED To Launch Functional Electrical Stimulation For The EksoGT ExoskeletonBRIEF-Ekso Bionic Partners With HASOMED To Launch Functional Electrical Stimulation For The EksoGT Exoskeleton
www.reuters.com - December 14 at 5:35 PM
ETFs with exposure to Ekso Bionics Holdings, Inc. : December 7, 2017ETFs with exposure to Ekso Bionics Holdings, Inc. : December 7, 2017
finance.yahoo.com - December 7 at 5:24 PM
Ekso Bionics Holdings, Inc. (EKSO)Ekso Bionics Holdings, Inc. (EKSO)
seekingalpha.com - November 29 at 9:56 AM
Ekso Bionics (EKSO) Pan-Euro Study Data on EksoGT Published in Spinal Cord JournalEkso Bionics (EKSO) Pan-Euro Study Data on EksoGT Published in Spinal Cord Journal
www.streetinsider.com - November 29 at 9:56 AM
Ekso Bionics (EKSO) in Focus: Stock Moves 6.6% Higher - NasdaqEkso Bionics (EKSO) in Focus: Stock Moves 6.6% Higher - Nasdaq
www.nasdaq.com - November 28 at 4:58 PM
Ekso Bionics (EKSO) Pan-Euro Study Data on EksoGT Published in Spinal Cord Journal - StreetInsider.comEkso Bionics (EKSO) Pan-Euro Study Data on EksoGT Published in Spinal Cord Journal - StreetInsider.com
www.streetinsider.com - November 28 at 4:58 PM
International Journal Spinal Cord Publishes Multicenter Pan-Euro Study of EksoGT™ - GlobeNewswire (press release)International Journal Spinal Cord Publishes Multicenter Pan-Euro Study of EksoGT™ - GlobeNewswire (press release)
globenewswire.com - November 28 at 8:50 AM
Ekso Bionics Holdings, Inc. (EKSO) Insider Sells $175,500.00 in StockEkso Bionics Holdings, Inc. (EKSO) Insider Sells $175,500.00 in Stock
www.americanbankingnews.com - November 27 at 7:54 PM
 Ekso Bionics Holdings, Inc. (EKSO) Given Consensus Recommendation of "Strong Buy" by Analysts Ekso Bionics Holdings, Inc. (EKSO) Given Consensus Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - November 24 at 9:12 PM
Deere stock rips higher after upgrading 2018 forecastDeere stock rips higher after upgrading 2018 forecast
finance.yahoo.com - November 24 at 10:46 AM
Everything points to a hot US economy—despite the latest Durable Goods missEverything points to a hot US economy—despite the latest Durable Goods miss
finance.yahoo.com - November 24 at 10:46 AM
This is what a Trump-stacked Federal Reserve will look likeThis is what a Trump-stacked Federal Reserve will look like
finance.yahoo.com - November 23 at 4:20 PM
Bitcoin barely bats an eye after $31 million cryptocurrency heistBitcoin barely bats an eye after $31 million cryptocurrency heist
finance.yahoo.com - November 23 at 4:20 PM
Today's surge in stocks kicks off the Santa Claus rally: NYSE traderToday's surge in stocks kicks off the Santa Claus rally: NYSE trader
finance.yahoo.com - November 23 at 4:20 PM
With Latest Update, FDA Approval Soon Could Send BTCY RippingWith Latest Update, FDA Approval Soon Could Send BTCY Ripping
finance.yahoo.com - November 20 at 7:02 PM
Ekso Bionics Holdings, Inc. (EKSO) Raised to "Sell" at ValuEngineEkso Bionics Holdings, Inc. (EKSO) Raised to "Sell" at ValuEngine
www.americanbankingnews.com - November 18 at 12:04 AM
Ekso Bionics Holdings, Inc. (EKSO) Stock Rating Lowered by Zacks Investment ResearchEkso Bionics Holdings, Inc. (EKSO) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - November 13 at 7:08 PM
Ekso Bionics Holdings, Inc. :EKSO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017Ekso Bionics Holdings, Inc. :EKSO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
finance.yahoo.com - November 13 at 11:35 AM
FY2017 EPS Estimates for Ekso Bionics Holdings, Inc. Cut by Analyst (EKSO)FY2017 EPS Estimates for Ekso Bionics Holdings, Inc. Cut by Analyst (EKSO)
www.americanbankingnews.com - November 13 at 3:36 AM
Ford is bringing robots into the workforceFord is bringing robots into the workforce
finance.yahoo.com - November 12 at 5:56 PM
Ford tests bionic auto workers - Seeking AlphaFord tests bionic auto workers - Seeking Alpha
seekingalpha.com - November 11 at 11:09 PM
Ford Just Created a Bionic EmployeeFord Just Created a Bionic Employee
www.thestreet.com - November 10 at 12:03 PM
Pre-Open Movers 11/10: (JCP) (DVAX) (HTZ) Higher; (TTD) (QTM) (GBT) Lower (more...)Pre-Open Movers 11/10: (JCP) (DVAX) (HTZ) Higher; (TTD) (QTM) (GBT) Lower (more...)
www.streetinsider.com - November 10 at 12:03 PM
Edited Transcript of EKSO earnings conference call or presentation 8-Nov-17 9:30pm GMTEdited Transcript of EKSO earnings conference call or presentation 8-Nov-17 9:30pm GMT
finance.yahoo.com - November 10 at 12:03 PM
Ekso Bionics Holdings, Inc. (EKSO) to Post Q1 2018 Earnings of ($0.07) Per Share, SunTrust Banks ForecastsEkso Bionics Holdings, Inc. (EKSO) to Post Q1 2018 Earnings of ($0.07) Per Share, SunTrust Banks Forecasts
www.americanbankingnews.com - November 10 at 10:50 AM
Ekso Bionics Holdings, Inc. (EKSO) Issues  Earnings ResultsEkso Bionics Holdings, Inc. (EKSO) Issues Earnings Results
www.americanbankingnews.com - November 9 at 6:32 PM
Ekso Bionics Holdings, Inc. to Host Earnings CallEkso Bionics Holdings, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 1:43 AM
Ekso Bionics Reports Third Quarter 2017 Financial ResultsEkso Bionics Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 9 at 1:43 AM
ETFs with exposure to Ekso Bionics Holdings, Inc. : November 7, 2017ETFs with exposure to Ekso Bionics Holdings, Inc. : November 7, 2017
finance.yahoo.com - November 8 at 6:05 AM
Ekso Bionics® to Report Third Quarter 2017 Financial Results on November 8, 2017 - GlobeNewswire (press release)Ekso Bionics® to Report Third Quarter 2017 Financial Results on November 8, 2017 - GlobeNewswire (press release)
globenewswire.com - November 2 at 12:18 AM
Ekso Bionics® to Report Third Quarter 2017 Financial Results on November 8, 2017Ekso Bionics® to Report Third Quarter 2017 Financial Results on November 8, 2017
finance.yahoo.com - November 1 at 7:14 PM
Ekso Bionics Holdings, Inc. (EKSO) Short Interest UpdateEkso Bionics Holdings, Inc. (EKSO) Short Interest Update
www.americanbankingnews.com - October 28 at 1:26 AM
ETFs with exposure to Ekso Bionics Holdings, Inc. : October 24, 2017ETFs with exposure to Ekso Bionics Holdings, Inc. : October 24, 2017
finance.yahoo.com - October 24 at 9:47 PM
Medical Supplies Stock Performance Review -- Tandem Diabetes Care, Ekso Bionics, OraSure Technologies, and Hill ... - PR Newswire (press release)Medical Supplies Stock Performance Review -- Tandem Diabetes Care, Ekso Bionics, OraSure Technologies, and Hill ... - PR Newswire (press release)
www.prnewswire.com - October 19 at 12:36 AM
ETFs with exposure to Ekso Bionics Holdings, Inc. : October 13, 2017ETFs with exposure to Ekso Bionics Holdings, Inc. : October 13, 2017
finance.yahoo.com - October 13 at 6:45 PM
Ekso Bionics® to Showcase the Latest Features of the EksoGT™ Wearable Exoskeleton at 2017 AAPM&R Annual ... - GlobeNewswire (press release)Ekso Bionics® to Showcase the Latest Features of the EksoGT™ Wearable Exoskeleton at 2017 AAPM&R Annual ... - GlobeNewswire (press release)
globenewswire.com - October 10 at 3:59 PM
Ekso Bionics® to Showcase the Latest Features of the EksoGT™ Wearable Exoskeleton at 2017 AAPM&R Annual AssemblyEkso Bionics® to Showcase the Latest Features of the EksoGT™ Wearable Exoskeleton at 2017 AAPM&R Annual Assembly
finance.yahoo.com - October 10 at 3:59 PM
Before You Invest In Ekso Bionics Holdings Inc (EKSO), Consider This FactorBefore You Invest In Ekso Bionics Holdings Inc (EKSO), Consider This Factor
finance.yahoo.com - October 5 at 5:26 PM
ETFs with exposure to Ekso Bionics Holdings, Inc. : October 2, 2017ETFs with exposure to Ekso Bionics Holdings, Inc. : October 2, 2017
finance.yahoo.com - October 3 at 10:56 AM
Comparing Ekso Bionics Holdings (EKSO) and Strata Skin Sciences (SSKN)Comparing Ekso Bionics Holdings (EKSO) and Strata Skin Sciences (SSKN)
www.americanbankingnews.com - September 30 at 6:26 AM
Ekso Bionics Appoints Ted Wang to its Board of Directors - GlobeNewswire (press release)Ekso Bionics Appoints Ted Wang to its Board of Directors - GlobeNewswire (press release)
globenewswire.com - September 22 at 10:19 PM
BRIEF-Ekso Bionics appoints Ted Wang to its board of directorsBRIEF-Ekso Bionics appoints Ted Wang to its board of directors
www.reuters.com - September 22 at 5:18 PM
Ekso Bionics (EKSO) Names Ted Wang to Board - StreetInsider.comEkso Bionics (EKSO) Names Ted Wang to Board - StreetInsider.com
www.streetinsider.com - September 22 at 8:36 AM
Ekso Bionics Appoints Ted Wang to its Board of DirectorsEkso Bionics Appoints Ted Wang to its Board of Directors
finance.yahoo.com - September 22 at 8:36 AM
Ekso Bionics Holdings (EKSO) versus Invuity (IVTY) Financial SurveyEkso Bionics Holdings (EKSO) versus Invuity (IVTY) Financial Survey
www.americanbankingnews.com - September 20 at 2:22 PM
ETFs with exposure to Ekso Bionics Holdings, Inc. : September 19, 2017ETFs with exposure to Ekso Bionics Holdings, Inc. : September 19, 2017
finance.yahoo.com - September 19 at 6:12 PM
Ekso Bionics Holdings, Inc. :EKSO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017Ekso Bionics Holdings, Inc. :EKSO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 6:03 PM
Unilife Corp (UNIS) versus Ekso Bionics Holdings (EKSO) Financial ContrastUnilife Corp (UNIS) versus Ekso Bionics Holdings (EKSO) Financial Contrast
www.americanbankingnews.com - September 18 at 12:02 PM
Critical Comparison: Invuity (IVTY) vs. Ekso Bionics Holdings (EKSO)Critical Comparison: Invuity (IVTY) vs. Ekso Bionics Holdings (EKSO)
www.americanbankingnews.com - September 18 at 4:28 AM
Ekso Bionics Holdings (EKSO) versus Invuity (IVTY) Head-To-Head ContrastEkso Bionics Holdings (EKSO) versus Invuity (IVTY) Head-To-Head Contrast
www.americanbankingnews.com - September 17 at 2:31 AM

SEC Filings

Ekso Bionics (NASDAQ:EKSO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Ekso Bionics (NASDAQ EKSO) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.